STAT3 and Hodgkins lymphoma: CD123 expresses on macrophages in the microenvironment of HL, suggesting that CD123-targeted therapies might impact on the tumor microenvironment (23).It was previously shown that TAMs can activate HL cell proliferation through the STAT3 pathway (24).